News
-
Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and Warrants
January 17, 2025 -
Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants
January 15, 2025 -
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market
January 3, 2025 -
Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash
November 21, 2024 -
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
November 15, 2024 -
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
October 10, 2024 -
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
September 27, 2024 -
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
September 13, 2024 -
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
September 12, 2024 -
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
September 10, 2024